Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut epithelial barrier integrity markers are molecules or proteins used to assess the health and function of the intestinal epithelial barrier. These markers include citrulline, I-FABP, zonulin, LBP, claudins, and calprotectin. Alterations in these biomarkers can provide insights into early detection of mucosal injury, monitoring disease progression/remission, and evaluating response to therapy targeting mucosal healing. Elevated levels often precede clinical symptoms or histological changes.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut Epithelial Barrier Integrity Markers (N/A).